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Abstract
Background
Chikungunya virus (CHIKV) is a mosquito-borne virus currently transmitted in about 60
countries. CHIKV causes acute flu-like symptoms and in many cases prolonged musculo-
skeletal and joint pain. Detection of the infection is mostly done using RT-RCR or ELISA,
which are not suitable for point-of-care diagnosis.
Methodology/Principal Findings
In this study, a reverse transcription recombinase polymerase amplification (RT-RPA) assay
for the detection of the CHIKV was developed. The assay sensitivity, specificity, and cross-
reactivity were tested. CHIKV RT-RPA assay detected down to 80 genome copies/reaction
in a maximum of 15 minutes. It successfully identified 18 isolates representing the three
CHIKV genotypes. No cross-reactivity was detected to other alphaviruses and arboviruses
except O'nyong'nyong virus, which could be differentiated by a modified RPA primer pair.
Seventy-eight samples were screened both by RT-RPA and real-time RT-PCR. The diag-
nostic sensitivity and specificity of the CHIKV RT-RPA assay were determined at 100%.
Conclusions/Significance
The developed RT-RPA assay represents a promising method for the molecular detection
of CHIKV at point of need.
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004953 September 29, 2016 1 / 15
a11111
OPEN ACCESS
Citation: Patel P, Abd El Wahed A, Faye O, Prüger
P, Kaiser M, Thaloengsok S, et al. (2016) A Field-
Deployable Reverse Transcription Recombinase
Polymerase Amplification Assay for Rapid Detection
of the Chikungunya Virus. PLoS Negl Trop Dis 10(9):
e0004953. doi:10.1371/journal.pntd.0004953
Editor: Maya Williams, Naval Medical Research
Center, UNITED STATES
Received: April 4, 2016
Accepted: August 3, 2016
Published: September 29, 2016
Copyright: © 2016 Patel et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: The authors received no specific funding
for this work.
Competing Interests: All authors have no financial
interests except MK is employed by GenExpress
Gesellschaft für Proteindesign and has commercial
interest in the molecular RNA standard. This does not
alter the authors´ adherence to all PLOS policies on
sharing data and materials.
Author Summary
CHIKV is transmitted to humans via mosquitos. CHIKV induces clinical signs similar to
Influenza, Dengue, and Zika viruses. We have developed a molecular assay for the detec-
tion of CHIKV genome based on isothermal„recombinase polymerase amplification
(RPA) assay”performed at 42°C. The result was obtained in maximum of 15 minutes,
which is 4–6 times faster than the current molecular diagnostic techniques. Our CHIKV
RPA assay is rapid and sensitive, as well as easy to use at the point of need.
Introduction
Chikungunya virus (CHIKV) is a mosquito-borne virus belonging to the genus alphavirus,
family Togaviridae and spread by Aedesmosquitoes. CHIKV is the aetiological agent of chi-
kungunya fever (CF) and was first isolated in 1952 from the serum of a febrile patient during
an outbreak in Tanzania, Africa [1]. CHIKV infection is characterized by an abrupt onset of
fever lasting two to five days, frequently accompanied by arthralgia. The disease is usually self-
limiting, but joint pain symptoms can persists for weeks up to years [2–4]. Other common
symptoms include muscle pain, headache, nausea, fatigue and rash similar to the dengue virus
infection. Besides CHIKV, the Alphavirus genus includes viruses such as O'nyong'nyong virus
(ONNV), Ross River virus (RRV), Barmah Forest virus (BFV), Sindbis virus (SNV) and
Mayaro virus (MAYV) [5].
Since its discovery in Africa, CHIKV has repeatedly caused outbreaks in Africa, India,
Southeast Asia, the Middle East and Europe with irregular intervals [6–10]. Phylogenetic analy-
sis of CHIKV showed that the virus has evolved into three distinct genotypes: Asian, West Afri-
can and Eastern/Central /South African (ECSA) [11]. A single-base mutation E1-A226V in a
strain of the ECSA genotype enhanced replication of the virus in Ae. albopictus, and led to a
large-scale epidemic on La Reunion in 2005 [12]. This ECSA genotype was subsequently asso-
ciated with epidemics in the Indian Ocean region, and the Asian genotype has been associated
with recent outbreaks in the Pacific region [13].
The first local transmission of CF in the Americas was reported from the Caribbean islands
in December 2013. The local transmission of the disease has been reported in 45 countries or
territories throughout world with more than 1.7 million suspected cases (CCDR October 20,
2015, http://www.cdc.gov/chikungunya/geo/index.html). It appears to have been introduced
twice to Brazil, once from the Pacific region and once from Africa [14].
Current diagnosis of CHIKV is based on three main laboratory methods: virus isolation,
reverse transcription-polymerase chain reaction (RT-PCR) and serological tests such as plaque
reduction neutralizing test (PRNT), enzyme-linked immunosorbent assays (ELISA) or immu-
nofluorescence test (IFT). Commonly, blood and serum samples are used as specimens for
CHIKV diagnosis. Depending on the type of sample and the time of sample collection relative
to symptoms (acute or convalescent phase of disease), an appropriate diagnostic method is
applied to the samples [15].
A pronounced viraemia of up to 109 viral genomes can be observed mainly on days 1–6
after onset of disease and in some cases for longer [16], therefore, virus isolation and RT-PCR
are performed on acute phase specimens collected during the first week after onset of symp-
toms. Several RT-PCR assays have been published for the detection of CHIKV RNA in clinical
specimens and mosquito samples [17–23]. Real-time RT-PCR based assays are suitable for
clinical diagnosis due to the closed tube assay format, the option for quantification of viral
load, high sensitivity and specificity. Serological tests are applied to either acute or convalescent
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phase samples for the detection of IgM and IgG anti-CHIKV antibodies. Serological diagnosis
is confirmed by direct detection of IgM anti-CHIKV antibodies or by determining a four-fold
increase in CHIKV-specific antibody titers in acute and convalescent samples by ELISA, IFT or
PRNT tests [15].
Since the clinical picture of CHIKV is similar to that of DENV and Zika virus, a simple and
rapid molecular assay would be needed to select the best treatment approach. The recombinase
polymerase amplification (RPA) assay utilizes enzymes and proteins in order to allow the
amplification of the DNA at a constant temperature (38–42°C) [24]. The presence of the ampli-
con is detected via the exo-probe, which include an internal abasic site mimic (tetrahydrofuran,
THF) flanking fluorophore and Quencher as well as pathogen-specific 30 and 15 bases at both
the 5´ and 3´ prime ends, respectively. Upon the hybridization of the exo-probe to the comple-
mentary sequence the Exonuclease III cleaves at the THF site and the fluorescence signal is
generated. RPA assay was successfully developed for the detection of DENV and YFV as well
as other human and veterinary pathogens [25–32]. Moreover, a mobile suitcase laboratory was
established for allowing the deployment of the RPA in the field for identifying Ebola virus
infected case [33].
In this study, we developed and evaluated a reverse-transcription recombinase polymerase
amplification (RT-RPA) assay as potential point-of-care (POC) diagnostic tool for rapid detec-
tion of CHIKV. The RT-RPA assay was designed by targeting the non-structure protein 1
(nsP1). The sensitivity and specificity of the method was evaluated using strains of the three
genotypes of CHIKV and compared to reference RT-PCR methods. Finally, the performance
of the RT-RPA assay was evaluated on acute-phase serum samples for clinical diagnosis of
CHIK.
Methods
Ethical Statement Clinical Samples
In total, the study included 78 patients with a history of sudden onset of fever, headache,
fatigue, nausea, vomiting, rash, myalgia and severe and very painful polyarthralgia suggestive
of CHIK infection. Fifty-eight plasma samples were provided by the Department of Microbiol-
ogy, Faculty of Science, Mahidol University, Bangkok, Thailand (Ethical approval ID: COA.
No. MU-IRB 2010/251.3108). Twenty CHIKV positive sera samples collected from patients
suspected to be infected by CHIKV during routine medical examination, were provided by
French National Reference Center for Arboviruses, Marseille, France. Patients had given oral
consent according to the national ethical regulations. All used samples were handled
anonymously.
Virus Preparations
All the different CHIKV virus strains (Table 1) used in this study were derived from cell culture
and kindly provided by the European Network for Diagnostics of Imported Viral Diseases
(ENIVD); the Bernard-Nocht Institute in Hamburg, Germany; French National Reference Cen-
ter for Arboviruses, Marseille, France and the Pasteur Institute of Dakar in Senegal. The Robert-
Koch Institute, Berlin in Germany and the Pasteur Institute de Dakar in Senegal provided differ-
ent flavivviruses, alphaviruses and Rift Valley Fever Virus (Table 2) for cross reactivity testing.
RNA Extraction
Viral RNA was isolated from 140 μl aliquots of cell culture supernatants or serum sample,
using the QIAamp Viral Mini Kit (QIAGEN, Hilden, Germany) according to the
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Table 1. List of the 18 isolates representing the three CHIKV genotypes. All isolates were screened with real-time RT-PCR assays and RT-RPA.
Name Isolate origin/year CHIKV clade Real-time RT-PCR (Ct) RT-RPA (Tt)
CHIKV 902/BHK ind. Ocean 01/2007 ECSA 23.00 3.7
CHIKV 236/ ind. Ocean 01/2007 ECSA 22.50 3.7
CHIKV BHK/3162 ind. Isolate 01/2007 ECSA 24.69 4.0
CHIKV La Réunion 684–1 La Réunion /2006 ECSA 24.01 3.7
CHIKV African S27 East Africa ECSA 21.47 3.7
CHIKV H20235 ST Martin/2013 Asia 16.33 3.7
CHIKV Ar D 93311 Senegal/1993 West African 17.76 2.7
CHIKV H D 103090 Senegal/1993 West African 20.65 3.3
CHIKV H D 103091 Senegal/1993 West African 21.58 3.3
CHIKV Ar A 30543 Côte d'Ivoire/1993 West African 19.67 5.3
CHIKV Ar A 30548 Côte d'Ivoire/1993 West African 19.22 3.3
CHIKV Ar D 122544 Senegal/1996 West African 24.49 2.7
CHIKV Ar D 128438 Senegal/1997 West African 22.39 2.7
CHIKV H D 131124 Senegal/1998 West African 20.27 3.0
CHIKV Ar D 156076 Senegal/2004 West African 18.93 3.3
CHIKV Ar D 175374 Senegal/2004 West African 20.89 3.0
CHIKV Ar D 175381 Senegal/2004 West African 23.43 3.0
CHIKV H D 180760 Senegal/2005 West African Not detected 5.3
doi:10.1371/journal.pntd.0004953.t001
Table 2. Reactivity of flaviviruses, phlebovirus and alphaviruses in the CHIKV RT-RPA assay using two different primers pairs. The RF2+RR2
detected only the CHIKV, but not other viruses. While RF+RR3 detected both CHIKV and O'nyong'nyong virus.
Family Name Strain RT-RPA assay
RF+RR3 RF2+RR2
Flaviviridae Dengue virus serotype 1 VR344 (Thai 1958 strain) - -
Dengue virus serotype 2 VR345 (TH-36 strain) - -
Dengue virus serotype 3 VR216 (H87 strain) - -
Dengue virus serotype 4 VR217 (H241 strain) - -
West Nile Virus Israel (lineage 1) H. Bin, Sheba Medical Center, Israel - -
West Nile Virus (lineage 2) B956/AY532665 - -
Yellow Fever Virus Asibi AY640598.1 - -
Yellow Fever Virus 17D 17D RKI #142/94/1 - -
Zika Virus MR766 - -
Japanse Encephalitis virus ATCC SA14-14-2 - -
Bunyaviridae Rift Valley Fever Virus ZH548 - -
Alphaviridae Ndumu virus - - -
Middelburg virus - - -
Babanki virus - - -
Zingilamo An B 1245 a - -
Semliki Forest - - -
Semliki Forest virus M1V2 Turana - -
Ross river fever virus T 48/DQ226993 - -
Barmah Forest virus BH2193/U73745 - -
Sindbis virus Edgar 339 - -
Venezuelan equine encephalitis virus VEEV 8–01 - -
O'nyong'nyong virus An D SS 234 + -
doi:10.1371/journal.pntd.0004953.t002
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manufacturer's instructions. RNA was eluted in 60–100 μl of elution buffer and stored at -80°C
until further use.
Primer and Probe Design for RT-RPA
To identify the most conserved regions in the CHIKV genome for primer and probe design of
the RPA assay, we first analyzed an alignment of fifty CHIKV full genome sequences from the
RNA virus database (http://bioafrica.mrc.ac.za/rnavirusdb/) using GENEIOUS [34]. The nsP1
gene region from nucleotide position 131–306 nt was chosen for final RT-RPA assay design. In
total, 196 Genbank CHIKV sequences containing the conserved nsP1 region were re-aligned
using GENEIOUS. Based on the alignment, two forward primers, two reverse primers and a
single probe (Table 3) covering all known variants of CHIKV sequences were selected.
RNA Standards
In-vitro RNA was synthesized using the RiboMAX Large Scale RNA Production System-T7
(Promega, Mannheim, Germany) according to the manufacturer´s instructions and quantified
using a Nanodrop ND-1000 spectrophotometer (Thermo Scientific, Dreieich, Germany).
Real-Time RT-PCR
CHIKV-genomic RNA was tested and quantified by an in-house real-time RT-PCR targeting
the E gene using in vitro transcribed RNA standards as described previously [35]. The real-
time RT-PCR assays is a CHIKV group-specific assay and was carried out in a one-step format
using an ABI 7500 real-time PCR system and the AgPath-ID One-Step RT-PCR Kit. To quan-
tify CHIKV genomic RNA copies, ten-fold serial dilutions of the standard in vitro transcribed
RNA ranging from 5 to 5 x 105 RNA copies/reaction were tested within the same sample run.
The sensitivity of this real-time RT-PCR was determined at nine RNA copies in 95% of the
cases by probit regression.
Additionally, a second real-time RT-PCR assay targeting the E gene based on 149 CHIKV
sequences was used [36]. It was performed using the LightCycler 480 RNAMaster Hydrolysis
Probes (Roche, Mannheim, Germany) on the LightCycler 2.0 and the following temperature
profile: RT at 63°C for 3 min, activation at 95°C for 30 sec and 45 cycles of 2-steps PCR at 95°C
for 5 sec and 60°C for 15 sec. This real-time RT-PCR had an analytical sensitivity of 39 RNA
molecules detected by performing the probit analysis.
CHIKV RT-RPA Assay
The real-time RT-RPA assay was performed in 50 μl reaction volume using the TwistAmp RT
exo kit (TwistDx, Cambridge, UK) which provides all enzymes and reagents necessary for the
reverse transcription step and DNA amplification in lyophilized pellets according to the manu-
facturer’s instruction. Briefly, 29.5 μl of rehydration solution were mixed with 7.2 μl of ddH2O,
420 nM of each primer and 210 nM of target specific RPA exo-probe. A total of 41.5 μl of this
master mix was dispensed into each tube of the eight-tubes strip and 5 μl of RNA template was
added to the master mix and mixed. Finally 46.5 μl of master mix/template solution was trans-
ferred to each lyophilized RPA pellet of the eight-tubes strip provided in the kit. For each sam-
ple, 3.5 μl magnesium acetate (280 mM) was added into the lid of the reaction tubes and the
tubes were closed carefully. Through centrifugation of tubes, the magnesium acetate was
dropped into each reaction simultaneously to trigger the RT-RPA reaction. The reaction tubes
were vortexed, centrifuged and then placed in the ESE Quant Tubescanner (Qiagen Lake Con-
stance GmbH, Stockach, Germany) for real-time monitoring of fluorescence. The reaction was
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performed at 39°C for 15 minutes, with brief mixing and centrifugation of reaction tubes after
four minutes. The resulting amplification curves were analyzed by ESEQuant Tube Scanner
software Version 1.0 and threshold values were determined by slope validation i.e. slope (mV/
min) values were compared in order to distinguish positive from negative results.
Analytical Sensitivity
A dilution range between 107 and 101 of the nsP1 RNA molecular standard was used to deter-
mine the CHIKV RPA assay sensitivity for two RPA primer pair combinations (RF+RR3 or
RF2+RR2, Table 3). A probit regression analysis was performed on eight RPA runs of each
combination using STATISTICA (StatSoft, Hamburg, Germany). Additionally, RNA extracts
were prepared from 10-fold serial dilutions of two CHIKV strains culture supernatant. RNA
extracts containing low viral RNA load were prepared in 5-fold serial dilution to determine the
limit of detection (LOD). Aliquots of these RNA extracts were stored at -80°C until further use.
The sensitivity of the RF+RR3 combination was evaluated by testing RNA extracts simulta-
neously on CHIKV RT-RPA and real-time RT-PCR assays in order to compare results and
determine the LOD of the RT-RPA assay. Additionally a panel of 18 different CHIKV strains
including strains from the current CHIKV outbreaks representing all known three genotypes:
Asian, West African and Eastern/Central /South African (ECSA) (Table 1) were tested.
Assay Cross-Reactivity
In total, twenty-two viruses including eleven alphaviruses, ten flaviviruses and one phlebovirus
were used to determine the assay cross reactivity (Table 2).
Diagnostic Sensitivity and Specificity
Twenty CHIKV positive sera and 58 plasma samples with suspected CHIKV infection were
tested by real-time RT-PCR and RT-RPA assays to evaluate diagnostic specificity and
Table 3. List of the oligonucleotides of the RT-RPA and real-time RT-PCR assays.
Assay format Oligo name Sequence 5´- 3´ Target
region
Orientation Position
NC004162
RT-RPA CHIKV RF2 TCA CAY CRA ATG ACC AYG CTA ATG CTA GAG C nsP1 S 171–201
CHIKV
RR2
TTC CTR TCC GAC ATC ATC CTC CTT GCT GGY GC AS 272–303
CHIKV RF TGC ARC GTG CGT ACC CCA TGT TTG AGG TGG AA S 129–160
CHIKV
RR3
TCC AGG ATG GTT GAG TCG GGR TCA ATT TCC T As 234–264
CHIKV
probe
TGA GTC GGG RTC AAT TTC CTG CTC TAT TAG XT X fT TAT RGC
TAG ATG CGA GA-Ph
S 204–253
real-time
RT-PCR 1
CHIKV F2 GCA TAY AGGGCY CAT ACMGCA TC E1 gene S 10354–10376
CHIKV R CAT GRT CGC CGT TTG CAT AS 10450–10433
CHIKV TM Cy5-AAG GAC GCG RAG CTT AGC TGA TGC-BBQ AS 10401–10378
real-time
RT-PCR 2
CHIKV FP1 YGA YCA YGCMGWCAC AG S 10443–10459
CHIKV
RP1
AAR GGY GGG TAG TCC ATG TT AS 10549–10568
CHIKV P2 6FAM -CCA ATG TCY TCMGCC TGG ACR CCK TT-TMR S 10486–10511
XT, BHQ1-dT; X, Tetrahydrofuran; fT, FAM-dT; Ph, phosphate; Y, C or T; R: A or G; W, A or T; K, G or T; M, A or C; S, original sequence; AS, reverse
complementary
doi:10.1371/journal.pntd.0004953.t003
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sensitivity of the assay. RNA was extracted from these clinical samples using the QIAamp Viral
RNAMini Kit and 5 μl of eluated RNA was tested in each assay.
Results
Design and Optimization of RT-RPA
For the development of the CHIKV-specific RT-RPA assay, two forward primers, two reverse
primers and one RPA probe were designed in the conserved nsP1 target region. To identify the
best primer combination, a total of four combinations of were tested on RNA sample of the
CHIKV LR strain. Fig 1 illustrates the results of testing the primer combinations and indicates
that all four primer combinations were able to amplify CHIKV RNA efficiently within a maxi-
mum of six minutes. However, the primer combination CHIKV RF/RR3 resulted in an earlier
amplification starting point (after 2.7 minutes) with s higher fluorescence intensity than the
other three combinations (Fig 1).
Analytical Sensitivity of RT-RPA Assay
The analytical sensitivity of both the RF+RR3 and RF2+RR2 combinations were determined
using the in vitro transcribed RNA standard (n = 8) (S1 Fig). The calculated sensitivity at 95%
probability was 23 and 4310 RNA molecules/reaction for RF+RR3 and RF2+RR2, respectively
(Fig 2).
Fig 1. Real-Time RT-RPA run with different combinations of the designed primers. Four primer combinations were tested with
the LR isolate (P): RF+RR2, RF2+RR2, RF+RR3 or RF2+RR3. The negative control (N) was water. The RF+RR3 yielded the best
RPA fluorescence signal.
doi:10.1371/journal.pntd.0004953.g001
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RNA extracts of a 10-fold serial dilution of two CHIKV strains culture supernatant (LR and
IN) were tested by CHIKV RT-RPA using the RF+RR3 primers and real-time PCR to deter-
mine the analytical sensitivity. Comparative data are plotted in Fig 3. The results indicated that
both the RT-RPA and the real-time PCR detected RNA linearly over 5 log10 -steps of a serial
dilution of viral RNA. Similar results were also obtained with the CHIKV IN strain (S1 Table).
To determine the LOD of the RT-RPA assay more precisely, six replicates of the RNA extracts
containing low viral RNA loads as determined with real-time PCR, were diluted in a 5-fold
Fig 2. Probit regression analyses of RT-RPA assays using two primer combinations. (A) RF+RR3 and
(B) RF2+RR2. The data sets of eight RT-RPA assay runs using serial dilutions of in vitro transcribed nsP1
RNA ranging from 107 to 101 RNAmolecules were included in the analysis. Triangle sensitivity value at 95%
probability.
doi:10.1371/journal.pntd.0004953.g002
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dilution series in the range of the LOD calculated by probit analysis for the RT-RPA using in
vitro transcribed RNA.
Tested by RT-RPA, 6 of 6 (100%) RT-RPA replicates were amplified at a dilution 10−5 con-
taining 361 and 467 RNA genome equivalents (GC)/reaction (rxn) for the LR and the IN strain,
respectively. At the dilution of 10−6 containing 80 and 92 GC/rxn for the LR and the IN strain,
respectively, 5 of 6 replicates were amplified by RT-RPA assay. At the lowest dilution of 10−7
containing 10 GC/rxn only 2 of 6 and 3 of 6 replicates were detected for both the LR and the
Fig 3. Comparison between the results of CHIKV RT-RPA RF/RR3 assay (A) and the real-time RT-PCR
(B) using 10-fold dilutions of extracted RNA from CHIKV isolate LR. Both assay amplified down to 80
genome copies (represented by 10−6 dilution of the CHIKV).
doi:10.1371/journal.pntd.0004953.g003
Rapid Detection of Chikungunya Virus
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IN strain. Overall the probit detection limit in 95% of cases for real-time RT-PCR was 10 GC/
rxn, whereas the LOD of RT-RPA was 80 GC/rxn.
Analytical Specificity and Cross-Reactivity of the RT-RPA Assay
The sensitivity of the RT-RPA assay was assessed by testing 18 CHIKV strains representing all
three genotype (Table 1), the specificity was tested with eleven different alphaviruses, ten flavi-
viruses and one phlebovirus (Table 2). The CHIKV RT-RPA assay utilizing RF+RR3 efficiently
detected all 18 CHIKV strains and the O'nyong'nyong virus (ONNV), while RT-RPA assay
using RF2+RR2 amplified only the CHIKV strains. There was no cross reactivity found to
other viruses of the cross reactivity panel (Table 2 and S2 Fig).
Performance of the RT-RPA Assay on Clinical Samples
The diagnostic sensitivity and specificity of the CHIKV RT-RPA assay was assessed with plasma
samples from 58 suspect CF cases and compared to two CHIKV specific real-time RT-PCR tests
during a field trial in Bangkok, Thailand. Both CHIKV real-time RT-PCR detected 36 out of 58
sample (62%) positive. The Ct values obtained by real-time RT-PCR for positive samples ranged
from 20.19 to 36.02 (1.6x104 -1x108 GC/rxn). In comparison to real-time RT-PCR, RT-RPA cor-
rectly identified all 36 positive samples and did not detect the 22 negative samples with 100% sensi-
tivity and specificity (PPV: 1, NPV: 1, Fig 4). Additionally, we tested 20 sera from acute CHIK
patients from France. All three methods efficiently detected 20 out of 20 CHIKV positive samples.
Discussion
CHIKV is treated symptomatically by use of painkillers and anti-inflammatory drugs. As there
is no effective specific antiviral drug and currently only experimental CHIKV vaccine develop-
ment. Laboratory diagnosis of CHIKV is very important for effective outbreak management
including clinical management and vector control. Therefore, there is a need for a reliable,
rapid and portable diagnostic method, which can be deployed in the field during outbreaks.
In this study, we developed a RT-RPA assay for rapid detection of CHIKV in clinical sam-
ples, which can be easily deployed to rural health care centers or used in field investigations.
We designed a highly sensitive set of RPA primers and exo-probe, which detect CHIKV down
to 80 GC/rxn. This detection limit is slightly higher than the 10 GC/rxn detected by reference
real-time RT-PCR methods. However, the sensitivity of RT-RPA was sufficient to detect
CHIKV infection in clinical samples from Thailand and France with an overall sensitivity and
specificity of 100% in comparison to real-time RT-PCR. Previous studies described high titer
viraemia exceeding 109 GC/ml in the acute phase of CF [37,38]. In our study of 20 CF acute
samples, viral load ranged from 1.6x106 -1x1010 GC/ml (1.6x104 -1x108 GC/rxn).
The RT-RPA assay detected a panel of 18 different CHIKV strains of all known three geno-
types. There was no cross-reactivity of the RT-RPA assay with tested common alpha- and arbo-
viruses except for ONNV detected with the primer combination (RF+RR3), while the
combination RF2+RR2 did not detect the ONNV (S2 Fig). Cross reactivity of CHIKV RT-RPA
assay to ONNV could be due to 85% similarity of the genomes of ONNV to CHIKV.
RT-RPA primers RF/RR3 harbour four mismatches in RF and seven mismatches in RR3 to
the ONNV sequences (S3 Fig). This seems to reflect the fact that RPA assays have been shown
to amplify target genes in the presence of up to nine mismatches [25,30]. Moreover, the posi-
tion of the mismatch did not influence the amplification step as in the real-time PCR [29].
However, we chose primer pair RF/RR3 due to its faster amplification (Tt: 3.3) and highly ana-
lytical sensitivity (23 RNA copies) in comparison to the more specific primer pair RF2/RR2
(Tt: 3.7 and analytical sensitivity: 4310). If necessary, the latter can be used for the
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differentiation between CHIKV and ONNV e.g. when used in ONNV endemic regions of
Africa whereas the former can be used in Asia, Europe and the Americas without any issue.
The RT-RPA assay using RF/RR3 demonstrated a sensitivity of 100% on CHIKV samples of
the recent external quality assessment (EQA) study for molecular diagnosis but also detected
one sample containing ONNV. Both real-time RT-PCR tests used in this study showed no
cross reactivity to ONNV which indicates superior specificity compared to commercial PCR
methods tested in the EQA study, in which 46.2% showed cross reactivity to ONNV [39].
Two loop-mediated isothermal amplification (LAMP) assays for the detection of CHIKV
have been published [40,41]. The LAMP assay require at least four primers and six binding
sites and results can be usually observed visually after 30–60 minutes [42]. Recent LAMP assay
developments begin to show shorter run times [43]. In contrast, the RPA assay is much faster
Fig 4. Results of screening clinical samples using real-time RT-RPA and RT-PCR assays. Thirty-six samples were
positive in both assays with 100% agreement. Twenty-nine dots are shown as seven spots overlap. No correlation was found
between RT-PCR and RT-RPA values (R = 0.2).
doi:10.1371/journal.pntd.0004953.g004
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(3–15 minutes) and utilized two primers and one probe i.e. three binding sites. In addition,
RPA reagents are provided in a lyophilized pellet stable at ambient temperature (25–38°C)
[26,28,33], which allow independence from the cooling chain.
The RPA is a promising technology to perform molecular assay at point of need. Neverthe-
less, the RPA primer and probe design is still challenging, as dozens of primers combinations
must be tested in order to select a functional one. The current RPA assay protocol requires four
pipetting steps, which is still less than the real-time PCR method but further development to
miniaturize the assay is required. The cost of test per sample is around 5 USD. Lowering the
cost to 1 USD will maximum its use in the affected countries.
The CHIKV RPA assay presented here is a promising tool for CHIKV diagnostics at the
point of need. Integration into a multimer or multiplex assay for simultaneous and differential
detection of CHIKV, Dengue virus and Zika virus as well as an internal positive control would
improve outbreak investigations, since the three viruses induce the same clinical picture upon
infection and increasingly co-circulate in many parts of the world. Furthermore, combination
with a simple extraction method for allowing isolation of virus or virus-infected cells from the
whole blood and simple lysis protocol will maximize its employment at low resource settings.
Supporting Information
S1 Fig. Reproducibility of CHIKV RPA assays employing the two primers combinations (A,
RF+RR3; B, RF2+RR2). The RPA assays were conducted eight times using 10-fold serial dilu-
tion of the RNA molecular standards. CHIKV RPA assay produced results between 2 to 12
minutes. 107−104 RNA molecules were detected 8 out of 8 runs applying both primers combi-
nations. RF+RR3 primers amplified 103−102 copies 8 out of 8 times, while 101, one out of eight
times. 103−101 RNA copies were not identified by the CHIKV RF2+RR2 RPA assay. The error
bars represent the rang.
(PDF)
S2 Fig. Results of testing ChikV (black) and ONNV (Red) samples with RT-RPA assays with
two primer pair combinations, A) RF+RR3 and (B) RF2+RR2. The RF+RR3 assay is more sen-
sitive but is able to amplify the ONNV gene, while the RF+RR3 is less sensitive but did not
detect the ONNV.
(PDF)
S3 Fig. Alignment of Chikungunya RT-RPA primers and exo-probe sequences with the
Chikungunya and O'nyong'nyong viruses sequence using GENEIOUS.
(PDF)
S1 Table. Determining the sensitivity of RT-RPA assay. Ten-fold serial dilutions of ChiKV
isolates LR and In, were tested in both real-time RT-PCR and RT-RPA.
(PDF)
S1 Checklist.
(PDF)
S1 Flowchart. A diagram represents the workflow of screening clinical samples using real-
time RT-PCR and RT-RPA assays.
(PDF)
S1 Approval. Ethical approval from the Mahidol University Institutional Review Board on
the use of the samples from suspected CHIKV-infected cases.
(PDF)
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